Skip to main content
Close
Publication

Administration of broadly neutralizing anti-HIV-1 antibodies at ART initiation maintains long-term CD8+ T cell immunity

See all publications

 

 

 

 

 

 

 

 

 

 

 

Not available in
This is not available in . You can go to the translated versions in these languages: